3:42 PM
 | 
Jan 08, 2019
 |  BC Extra  |  Financial News

Venture roundup: Apic, Stelexis, Biond, Keros

Gene therapy company Apic Bio Inc. (Cambridge, Mass.) and cancer company Stelexis Therapeutics LLC (New York, N.Y.) each announced series A rounds this week of at least $40 million.

Other companies that announced venture rounds this week include Biond Biologics Ltd. (Misgav Industrial Park, Israel), which raised $17 million in a series B round, and Keros Therapeutics Inc. (Lexington, Mass.), which raised a $23 million series B round.

Apic plans to use its $40 million series A to develop...

Read the full 372 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >